Summary of Significant Accounting Policies (Tables)

9 Months Ended

Oct. 31, 2016

Accounting Policies [Abstract]

Schedule of Inventories

Inventory was comprised of the following at October 31, 2016 and January 31, 2016:

	October 31, 2016		January 31, 2016
Finished goods	$	459,504	$	252,752

Schedule of Property and Equipment Estimated Useful Lives

Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment	2-7 years
Furniture and fixtures	3-5 years
Leasehold improvements	3-10 years

Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

	Nine Months Ended October 31, 2016		Nine Months Ended October 31, 2015
Gross Sales	$	12,976,986	$	9,583,170
Less: Slotting, Discounts, Allowances		338,504		252,911
Net Sales	$	12,638,482	$	9,330,259

Schedule of Fair Value of Share Based Payments

For the nine months ended October 31, 2016, when computing fair value of share-based payments, the Company has considered the following variables:

	October 31, 2016
Risk-free interest rate		1.25% to 1.33	%
Expected life of grants		2.5 to 3.5 years
Expected volatility of underlying stock		172% to 179	%
Dividends		0	%

Schedule of Earnings Per Share Basic and Diluted Net Income Attributable to Common Stockholders

The computations of basic and diluted net income attributable to common stockholders are as follows:

	For the Three Months Ended
	October 31, 2016
	Income		Shares (a)
Net income attributable to common stockholders	$	33,803
Basic net income per common share	$	0.00		27,257,834
Net income attributable to common stockholders	$	33,803		27,257,834
Dilutive securities:
Options		-		250,000
Diluted net income	$	33,803		27,507,834
Diluted net income per common share	$	0.00

(a) - Weighted-average common shares outstanding.

Schedule of Common Stock Equivalents

The Company had the following potential common stock equivalents at October 31, 2016:

Series A Preferred	3,466,667
Common stock warrants, exercise price range of $0.68-$2.50	4,964,734
Common stock options, exercise price of $0.39-$2.97	799,404
Total common stock equivalents	9,230,805

The Company had the following potential common stock equivalents at October 31, 2015:

Series A Preferred	1,792,593
Common stock warrants, exercise price range of $0.68-$2.50	2,976,587
Common stock options, exercise price of $1.00-$2.97	496,404
Total common stock equivalents	5,265,584